|
1
|
Noronha IL, Fujihara CK and Zatz R: The
inflammatory component in progressive renal disease - are
interventions possible? Nephrol Dial Transplant. 17:363–368. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Badid C, Vincent M, Fouque D, Laville M
and Desmoulière A: Myofibroblast: A prognostic marker and target
cell in progressive renal disease. Ren Fail. 23:543–549. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Roberts IS, Burrows C, Shanks JH, Venning
M and McWilliam LJ: Interstitial myofibroblasts: Predictors of
progression in membranous nephropathy. J Clin Pathol. 50:123–127.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Razzaque MS and Taguchi T: Cellular and
molecular events leading to renal tubulointerstitial fibrosis. Med
Electron Microsc. 35:68–80. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zeisberg M, Strutz F and Müller GA: Renal
fibrosis: An update. Curr Opin Nephrol Hypertens. 10:315–320. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Eddy AA: Molecular basis of renal
fibrosis. Pediatr Nephrol. 15:290–301. 2000. View Article : Google Scholar
|
|
7
|
Fredholm BB: Adenosine, an endogenous
distress signal, modulates tissue damage and repair. Cell Death
Differ. 14:1315–1323. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Eltzschig HK, Thompson LF, Karhausen J,
Cotta RJ, Ibla JC, Robson SC and Colgan SP: Endogenous adenosine
produced during hypoxia attenuates neutrophil accumulation:
Coordination by extracellular nucleotide metabolism. Blood.
104:3986–3992. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tang J, Jiang X, Zhou Y, Xia B and Dai Y:
Increased adenosine levels contribute to ischemic kidney fibrosis
in the unilateral ureteral obstruction model. Exp Ther Med.
9:737–743. 2015.PubMed/NCBI
|
|
10
|
Chunn JL, Mohsenin A, Young HW, Lee CG,
Elias JA, Kellems RE and Blackburn MR: Partially adenosine
deaminase-deficient mice develop pulmonary fibrosis in association
with adenosine elevations. Am J Physiol Lung Cell Mol Physiol.
290:L579–L587. 2006. View Article : Google Scholar
|
|
11
|
Chunn JL, Molina JG, Mi T, Xia Y, Kellems
RE and Blackburn MR: Adenosine-dependent pulmonary fibrosis in
adenosine deaminase-deficient mice. J Immunol. 175:1937–1946. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chunn JL, Young HW, Banerjee SK, Colasurdo
GN and Blackburn MR: Adenosine-dependent airway inflammation and
hyperresponsiveness in partially adenosine deaminase-deficient
mice. J Immunol. 167:4676–4685. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
14
|
Strutz F and Zeisberg M: Renal fibroblasts
and myofibroblasts in chronic kidney disease. J Am Soc Nephrol.
17:2992–2998. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen CZ and Raghunath M: Focus on
collagen: in vitro systems to study fibrogenesis and antifibrosis
state of the art. Fibrogenesis Tissue Repair. 2:72007. View Article : Google Scholar
|
|
16
|
Blackburn MR, Volmer JB, Thrasher JL,
Zhong H, Crosby JR, Lee JJ and Kellems RE: Metabolic consequences
of adenosine deaminase deficiency in mice are associated with
defects in alveogenesis, pulmonary inflammation, and airway
obstruction. J Exp Med. 192:159–170. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Linden J: Adenosine in tissue protection
and tissue regeneration. Mol Pharmacol. 67:1385–1387. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Van Belle H, Goossens F and Wynants J:
Formation and release of purine catabolites during hypoperfusion,
anoxia, and ischemia. Am J Physiol. 252:H886–H893. 1987.PubMed/NCBI
|
|
19
|
Rego AC, Santos MS and Oliveira CR:
Adenosine triphosphate degradation products after oxidative stress
and metabolic dysfunction in cultured retinal cells. J Neurochem.
69:1228–1235. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wei CJ, Li W and Chen JF: Normal and
abnormal functions of adenosine receptors in the central nervous
system revealed by genetic knockout studies. Biochim Biophys Acta.
1808:1358–1379. 2011. View Article : Google Scholar
|
|
21
|
Mi T, Abbasi S, Zhang H, et al: Excess
adenosine in murine penile erectile tissues contributes to priapism
via A2B adenosine receptor signaling. J Clin Invest. 118:1491–1501.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Rudolphi KA, Schubert P, Parkinson FE and
Fredholm BB: Adenosine and brain ischemia. Cerebrovasc Brain Metab
Rev. 4:346–369. 1992.PubMed/NCBI
|
|
23
|
Schubert P, Rudolphi KA, Fredholm BB and
Nakamura Y: Modulation of nerve and glial function by adenosine -
role in the development of ischemic damage. Int J Biochem.
26:1227–1236. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhu JF, Tang LM and Li DC: Activation of
adenosine 2A receptor attenuating oxidative stress on
small-for-size liver transplantation. Chin J Bases And Clin In Gen
Surg. 17:243–247. 2010.
|
|
25
|
Grenz A, Osswald H, Eckle T, Yang D, Zhang
H, Tran ZV, Klingel K, Ravid K and Eltzschig HK: The reno-vascular
A2B adenosine receptor protects the kidney from ischemia. PLoS Med.
5:e1372008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lu Q, Sakhatskyy P, Newton J, et al:
Sustained adenosine exposure causes lung endothelial apoptosis: a
possible contributor to cigarette smoke-induced endothelial
apoptosis and lung injury. Am J Physiol Lung Cell Mol Physiol.
304:L361–L370. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yap SC and Lee HT: Adenosine and
protection from acute kidney injury. Curr Opin Nephrol Hypertens.
21:24–32. 2012. View Article : Google Scholar :
|
|
28
|
Mubagwa K and Flameng W: Adenosine,
adenosine receptors and myocardial protection: an updated overview.
Cardiovasc Res. 52:25–39. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Leask A: Towards an anti-fibrotic therapy
for scleroderma: targeting myofibroblast differentiation and
recruitment. Fibrogenesis Tissue Repair. 3:82010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Malmström J, Lindberg H, Lindberg C, et
al: Transforming growth factor-beta 1 specifically induce proteins
involved in the myofibroblast contractile apparatus. Mol Cell
Proteomics. 3:466–477. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ohtaka A, Ootaka T, Sato H and Ito S:
Phenotypic change of glomerular podocytes in primary focal
segmental glomerulosclerosis: Developmental paradigm. Nephrol Dial
Transplant. 17(Suppl 9): 11–15. 2002. View Article : Google Scholar
|
|
32
|
Jinde K, Nikolic-Paterson DJ, Huang XR,
Sakai H, Kurokawa K, Atkins RC and Lan HY: Tubular phenotypic
change in progressive tubulointerstitial fibrosis in human
glomerulonephritis. Am J Kidney Dis. 38:761–769. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Johnson RJ, Iida H, Alpers CE, Majesky MW,
Schwartz SM, Pritzi P, Gordon K and Gown AM: Expression of smooth
muscle cell phenotype by rat mesangial cells in immune complex
nephritis. Alpha-smooth muscle actin is a marker of mesangial cell
proliferation. J Clin Invest. 87:847–858. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ng YY, Fan JM, Mu W, Nikolic-Paterson DJ,
Yang WC, Huang TP, Atkins RC and Lan HY: Glomerular
epithelial-myofibroblast transdifferentiation in the evolution of
glomerular crescent formation. Nephrol Dial Transplant.
14:2860–2872. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Eddy AA: Molecular insights into renal
interstitial fibrosis. J Am Soc Nephrol. 7:2495–2508.
1996.PubMed/NCBI
|
|
36
|
Zhang G, Moorhead PJ and el Nahas AM:
Myofibroblasts and the progression of experimental
glomerulonephritis. Exp Nephrol. 3:308–318. 1995.PubMed/NCBI
|
|
37
|
Hewitson TD, Wu HL and Becker GJ:
Interstitial myofibroblasts in experimental renal infection and
scarring. Am J Nephrol. 15:411–417. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ling H, Li X, Jha S, Wang W, Karetskaya L,
Pratt B and Ledbetter S: Therapeutic role of TGF-beta-neutralizing
antibody in mouse cyclosporin A nephropathy: Morphologic
improvement associated with functional preservation. J Am Soc
Nephrol. 14:377–388. 2003. View Article : Google Scholar : PubMed/NCBI
|
